Min H. Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
HER2-low and ultralow breast cancer: interobserver challenges and lessons from a consensus study.
Journal: Journal of pathology and translational medicine
Published: December 17, 2025
Patterns of Progression After First-Line Systemic Therapy in Metastatic Breast Cancer and the Potential of ctDNA to Guide Metastasis-Directed Therapy: Implications for Breast Oligometastases Management.
Journal: International journal of radiation oncology, biology, physics
Published: October 04, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.
Journal: JCO precision oncology
Published: October 02, 2025
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
Journal: Clinical and molecular hepatology
Published: September 09, 2025
Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: August 23, 2025
Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer.
Journal: Genome biology
Published: August 08, 2025
Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer.
Journal: Journal of breast cancer
Published: July 23, 2025
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).
Journal: Breast (Edinburgh, Scotland)
Published: January 06, 2025
Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 03, 2024
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).
Journal: BMC cancer
Published: September 06, 2024
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: June 11, 2024
Low Skeletal Muscle Radiodensity Predicts Response to CDK4/6 Inhibitors Plus Aromatase Inhibitors in Advanced Breast Cancer.
Journal: Journal of cachexia, sarcopenia and muscle
Published: May 24, 2024
Last Updated: 09/26/2026